Delic Holdings Aktie Logo
CA24689E1079
A3C4LT
DELCF

Delic Holdings Aktie

Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last year, Delic Holdings Aktie had revenue of €1.38m and net profit of -€7.79m
(EUR) 2021
YoY
Revenue 1.38m -
Gross profit -28.52k 40.74%
Net profit -7.79m 494.69%
EBITDA -5.06m 391.88%

Fundamentals

Metric Value
Market capitalization
€15.71k
Number of shares
88.03m
52-week high/low
€0.000268 - €0.0000446
Dividends No
Beta
0.23
P/E ratio
0.00
PEG ratio
0.00
P/B ratio
0.00
P/S ratio
0.01

Company profile

Delic Holdings Corp. provides various medicines and treatments in the United States and Canada. It operates The Delic, a creative platform that creates and hosts public discourse about psychedelic culture; Meet Delic, which organizes event to promote topics, such as safety and harm reduction, Hollywood, mental health and psychedelics, the power of integration, human performance, medicine, and other topics; Reality Sandwich, a public online education platform with approximately 10,000 pieces of content, including psychedelic guides, news, and culture; and Delic Radio, a podcast that discusses topics related to the psychedelic space with experts comprising discussions relating to news, science, culture, medicine, current affairs, and policy. The company also focuses on developing intellectual property through research and development for cannabis and psychedelics. In addition, it owns and operates two ketamine infusion treatment clinics; and thirteen ketamine infusion treatment clinics. The company is headquartered in Vancouver, Canada.

Name
Delic Holdings Aktie
CEO
Kevin Nicholson
Headquarters Vancouver, bc
Canada
Website
IPO
19/01/2021
Employees 116

Ticker symbols

Exchange Symbol
Pnk
DELCF
đŸȘ

Parqet  uses cookies. Learn more